PD-L1/ CD274 – RMab


IHC of PD-L1 on an FFPE Hodgkins Lymphoma Tissue

United States
Research Use
Safety Data Sheet
Control Slides
Intended UseFor ASR Use.
Summary and ExplanationProgrammed death-ligand 1 (PD-L1) also known as CD274 or B7 homolog 1 (B7-H1) is a protein that in humans is encoded by the CD274 gene. Programmed death-ligand 1 (PD-L1) is a 40 kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the immune system during particular events such as pregnancy, tissue allografts, autoimmune disease and other diseases.The upregulation of PD-L1 may allow cancers to evade the host immune system. An analysis of tumor specimens from patients with renal cell carcinoma found that high tumor expression of PD-L1 was associated with increased tumor aggressiveness and a 4.5-fold increased risk of death. Ovarian cancer patients with higher expression of PD-L1 had a significantly poorer prognosis than those with lower expression. PD-L1 expression correlated inversely with intraepithelial CD8+ T-lymphocyte count, suggesting that PD-L1 on tumor cells may suppress antitumor CD8+ T cells. The PD-1/PD-L1 interaction is implicated in autoimmunity from several lines of evidence. In humans, PD-L1 was found to have altered expression in pediatric patients with Systemic lupus erythematosus. Studying isolated PBMC from healthy children, immature myeloid dendritic cells and monocytes expressed little PD-L1 at initial isolation, but spontaneously up-regulated PD-L1 by 24 hours. In contrast, both mDC and monocytes from patients with active SLE failed to upregulate PD-L1 over a 5 day time course, expressing this protein only during disease remissions.
Antibody TypeRabbit MonoclonalCloneRBT-PDL1
IsotypeIgGReactivityParaffin, Frozen
LocalizationMembranousControlThymus, Tonsil, Placenta, Lymphoblastic Lymphoma, Hodgkin’s Lymphoma Tissue
PresentationPD-L1 is a rabbit monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Catalog No.Antibody TypeDilutionVolume/QTY
BSB 2649Tinto PredilutedReady-To-Use3.0 ml
BSB 2650Tinto PredilutedReady-To-Use7.0 ml
BSB 2651Tinto PredilutedReady-To-Use15.0 ml
BSB 2652Concentrated1:25-1:1000.1 ml
BSB 2653Concentrated1:25-1:1000.5 ml
BSB 2654Concentrated1:25-1:1001.0 ml
BSB 2655Control Slides5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.

Related products

Skip to content